New imaging technique accurately detects aggressive kidney cancer
WEB1 day ago · Kidney cancers, known as renal cell carcinomas, make up 90% of solid kidney tumors. Every year more than 81,000 people in the United States are diagnosed with kidney cancer. Among the many types of these cancers, the most common and deadly is clear-cell renal cell carcinoma, which accounts for …
New imaging technique accurately detects aggressive kidney cancer
WEB1 day ago · The new imaging method accurately identified the presence of cancer in most cases while minimizing false positives, demonstrating a high performance with 85.5% sensitivity and 87.0% specificity ...
Single-port partial nephrectomy offers innovative treatment for ...
WEB23 hours ago · For these reasons, the single-port approach has become increasingly common in robotic prostate cancer surgery. However, the single-port robot has not yet been widely used for kidney cancer surgery. According to Dr. Khanna, there are unique advantages of single-port approaches to kidney surgery beyond simply the number and size of incisions.
Study reveals potential new way to stop a common kidney cancer
WEBApr 22, 2024 · Now, in a study led by Melissa Wolf, PhD, researchers at Vanderbilt University Medical Center have identified cancer cell-specific genetic alterations that reprogram the immune “landscape,” thereby driving tumor growth, and discovered a potential new drug target for stopping it.
Advances in treating kidney cancer
WEBMay 30, 2024 · Kidney cancer is one the most common cancers in the U.S., with 81,610 new cases estimated in 2024. Mayo Clinic sees a high volume of kidney cancer cases and is among the most experienced institutions in treating kidney tumors.
Adjuvant Keytruda Improves Kidney Cancer Survival - NCI
WEBMay 21, 2024 · The findings mark the first time a post-surgical, or adjuvant, treatment for kidney cancer has been shown to help people live longer. Based on earlier results from this trial, called KEYNOTE-564, the Food and Drug Administration (FDA) approved pembrolizumab in 2021 as an adjuvant treatment for kidney cancer.
Subcutaneous Versus IV Nivolumab for Kidney Cancer - NCI
WEBMar 13, 2024 · For people with advanced kidney cancer, an injectable form of nivolumab (Opdivo) is a suitable alternative to the original intravenous form, early results from a clinical trial have shown. Experts say the injectable form makes the treatment quicker and easier for patients to receive.
FDA approves kidney cancer therapy after Dana-Farber-led …
WEBDec 15, 2023 · Belzutifan, a HIF-2α inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with advanced kidney cancer previously treated with immune checkpoint inhibitors and anti-angiogenic therapies.
New study provides genomic insights into kidney cancer risk
WEBApr 26, 2024 · In a new analysis of genetic susceptibility to kidney cancer, an international team of researchers has identified 50 new areas across the genome that are associated with the risk of developing kidney cancer.
Mayo Clinic Minute: Advances in treating kidney cancer
WEBApril 4, 2024. Kidney cancer is one the most common cancers in the U.S., with over 81,000 new diagnoses in 2023 alone. Mayo Clinic sees a high volume of kidney cancer cases and is among the most experienced institutions in treating kidney tumors.